Literature DB >> 8392682

Serological evidence of equine arteritis virus in donkeys in South Africa.

J T Paweska1, B J Barnard.   

Abstract

This paper reports the first serological evidence of exposure of donkeys to equine arteritis virus. Seven hundred and thirty-four serum samples collected between 1989 and 1992 from donkeys in different areas of South Africa were examined for the presence of antibodies against this virus by a microneutralization test. Seventeen percent of serum samples tested positive. The distribution of seropositive animals varied from none in the western Cape Province and the Transvaal Highveld to 30% in the northern Transvaal. The country-wide distribution of serologically positive donkeys suggests a longstanding presence of the virus in South Africa.

Entities:  

Mesh:

Year:  1993        PMID: 8392682

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  4 in total

1.  Intrahost Selection Pressure Drives Equine Arteritis Virus Evolution during Persistent Infection in the Stallion Reproductive Tract.

Authors:  Bora Nam; Zelalem Mekuria; Mariano Carossino; Ganwu Li; Ying Zheng; Jianqiang Zhang; R Frank Cook; Kathleen M Shuck; Juliana R Campos; Edward L Squires; Mats H T Troedsson; Peter J Timoney; Udeni B R Balasuriya
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

2.  Sexual and in-contact transmission of asinine strain of equine arteritis virus among donkeys.

Authors:  J T Paweska; D H Volkmann; B J Barnard; E D Chirnside
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

3.  Equine arteritis virus.

Authors:  A L Glaser; E D Chirnside; M C Horzinek; A A de Vries
Journal:  Theriogenology       Date:  1997-04-15       Impact factor: 2.740

4.  Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus.

Authors:  E D Chirnside; P M Francis; A A de Vries; R Sinclair; J A Mumford
Journal:  J Virol Methods       Date:  1995-07       Impact factor: 2.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.